Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Baltimore Marriott Waterfront

05 feb 2024 7:00 a.m. - 07 feb 2024 1:00 p.m.

700 Aliceanna Street , Baltimore, MD 21202

Global Pharmacovigilance and Risk Management Strategies Conference

Register for 2 or more short courses and save $150 off your registration fee!

Session 6: Application and Use of Machine Learning, Artificial Intelligence, Automation, and Technology in Pharmacovigilance

Session Chair(s)

Susan  Kindig, JD, MD

Susan Kindig, JD, MD

Prior Executive Director, Medical and Drug Safety

United States

This session will discuss use cases for Analytical/traditional AI and Generative AI and analyze the opportunities for expanding its’ impact/use. We will look at the impact of digital health on pharmacovigilance and forces at play with it’s ongoing impact. Lastly, we will explore ChatGPT for Safety professionals.

Learning Objective :
  • Develop an understanding of the practical uses of Analytical and Generative AI in pharmacoviglinace
  • Acquire targeted knowledge to evaluate and apply ChatGPT's capabilities within the context of safety operations
  • Leave with a clear framework for assessing the impact of Digital Health on Pharmacovigilance, including its benefits and challenges

Speaker(s)

Sibel D. Guerler, MSc

Digital Health: A BooM or Burden to Pharmacovigilance?

Sibel D. Guerler, MSc

Bristol-Myers Squibb Company, Switzerland

Head, Innovation, Partnerships & Process Optimization, WorldWide Patient Safety

Tracey  Boone, MBA

Use cases for Analytical/traditional AI and Generative AI: Where are the opportunities?

Tracey Boone, MBA

AbbVie, United States

Director

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.